Banking Business Investment Services Investments News

Oppenheimer Builds Out Healthcare Investment Banking Team To Support Accelerating Growth

Oppenheimer Builds Out Healthcare Investment Banking Team To Support Accelerating Growth

Jonathan Fassberg Named Vice Chairman of Healthcare Investment Banking, Brian Korb Joins as Managing Director and Don Ritucci Appointed Head of M&A for Firm’s Healthcare Investment Banking Team

Oppenheimer Hits Record Deal Volume in the Sector as it Successfully Concludes Annual Healthcare Conference

Oppenheimer & Co. Inc., a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings, announced the continued build-out of its Healthcare leadership team within the firm’s Investment Banking business.  The Healthcare Investment Banking team has added Jonathan Fassberg in the newly created role of Vice Chairman, Brian Korb as Managing Director, and Don Ritucci as Managing Director and Head of Healthcare Mergers and Acquisitions (“M&A”).

The addition of these new senior executives reflects Oppenheimer’s continued leadership in aligning M&A, capital raising and other investment banking services across the healthcare space, as well as the firm’s commitment to continuously enhance its capabilities in this large and fast-growing sector.

Read More: iShares Takes Steps to Lead Industry in Style Investing

Mr. Fassberg, and Mr. Korb will be based in New York and will report to Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking.  Don Ritucci, also based in New York, will report to Robert Lowenthal, Head of Investment Banking.

Read More: Deloitte: Hastened by the Pandemic, Global Enterprises Increase Investments in Advanced Wireless

Mr. Fassberg said, “I am excited to help drive the next stage of growth and success for Oppenheimer’s Healthcare Investment Banking group.  There has never been a better moment to enhance Oppenheimer’s position as the clear investment bank of choice for healthcare, biotech, and life sciences firms.  The opportunities emerging in this space have never been greater for firms like Oppenheimer that have a proven ability to serve healthcare businesses seeking to expand via M&A and capital raising transactions that are thoughtfully structured and flawlessly executed.”

Read More: Newlink Group Raises $300 Million In Funding From Leading Financial Institutions

Related posts

SGX Partners with Baton Systems to Streamline Collateral Workflow

Fintech News Desk

Expert.ai Strengthens Business Agreement With Multinational Insurance Company RSA

Fintech News Desk

EY And AuditBoard Form An Alliance For Innovative Risk Management Services

Fintech Staff Writer
1